Embedded Files
March 2025
Our recent collaborative research has been published in Blood (Impact Factor: 21.0).
NKG2D-mediated cytotoxicity of CD4 cytotoxic T cells in multiple myeloma. Blood. 2025; 146(4):456-470.
December 2024
A new paper has been published in Cancer Commun. (Impact Factor: 20.1).
IL2-mediated modulation of small extracellular vesicles secretion and PD-L1 expression: a novel perspective for neutralizing immune suppression within cancer cells. Cancer Commun. 2024; 44(12):1422-1426.
July 2024
We are proud to announce that our lab, in collaboration with Harvard Medical School and KIST, has been awarded a prestigious STEAM Research Program grant from the National Research Foundation of Korea.
This highly competitive award recognizes the innovative potential of our joint initiative and provides critical support for advancing cutting‑edge research toward the development of a novel therapeutic cancer vaccine.
March 2023
Congratulations to Seongmin, Nawon, and Minchae for their publication in BMB Rep. (Impact Factor: 5.041).
CD4+ cytotoxic T cells: an emerging effector arm of anti-tumor immunity. BMB Rep. 2023; 56(2):140-144.
December 2022
A perspective article from our lab and Zhang's lab at Harvard Medical School has been published in Trends Immunol. (Impact Factor: 19.709).
Does Delayed EBV Infection contribute to Rising Childhood Cancers? Trends Immunol. 2022; 43(12):956-958.
October 2022
A new paper has been published in Clin Cancer Res. (Impact Factor: 13.801).
Facts and hopes in the relationship of EBV with cancer immunity and immunotherapy. Clin Cancer Res. 2022; 28(20):4363-4369.
September 2022
The Choi lab was awarded a prestigious and highly selective grant ("중견연구") from the National Research Foundation of Korea.
Page updated
Google Sites
Report abuse